Charles (Charly) J. Lockwood
Executive Vice President, USF Health
Dean, USF Health Morsani College of Medicine

As executive vice president of USF Health, Dr. Lockwood leads the Morsani College of Medicine (MCOM), the Taneja College of Pharmacy, and the Colleges of Nursing and Public Health, as well as the School of Physical Therapy & Rehabilitation Sciences and Graduate Biomedical Sciences. He also oversees the USF Health faculty group practice, which with more than 1,000 providers is one of the largest multispecialty practices in Florida. Dr. Lockwood also serves as the MCOM dean and as a professor in its Department of Obstetrics and Gynecology. He holds a secondary appointment as a professor in the USF Health College of Public Health. Lockwood assumed all these leadership roles when he joined USF Health in May 2014 and has served as an EVP at Tampa General Hospital (TGH) since 2015. 

As dean of the Morsani College of Medicine, Dr. Lockwood has overseen a major re-organization of all three missions – education, research, and clinical care. Applications to the school have increased over 40% over the past 8 years, while the median MCAT score has increased from the 78th to 95th percentile and the mean GPA of matriculants has increased from 3.5 to 3.9. Student performance on the USMLE Step 1 and 2 exams has dramatically improved and over 90% of students complete research theses. In addition, the percent of students recruited from groups traditionally underrepresented in medicine (URM) increased from 7% in 2014 to 18% in 2022.

Beginning in 2015, Dr. Lockwood focused recruitment of investigators funded by the National Institutes of Health (NIH) on newly created cardiovascular and neuroscience institutes and a global infectious disease program. Because of aggressive recruitment, total MCOM faculty research awards, including that of faculty based at USF Health affiliates, increased from $128 million in 2014 to $305 million in 2021 and NIH grant expenditures increased from $97 million to $120 million. In addition, non-cancer clinical trial funding has tripled to over $20 million. Dr. Lockwood also helped develop several novel cross-campus transdisciplinary programs, such as a Medical Engineering Department. Driven by these successes, MCOM’s U.S. News & World Report rankings have climbed from 80th in 2014 to 46th in 2022, making MCOM the fastest rising research medical school in these rankings for the past decade.  

In the clinical practice, from fiscal year 2014 to fiscal year 2022, patient volume grew 30%, revenue increased more than 100%, from $192 million to $395 million and a $4 million annual loss was converted to a $27.2 million surplus. Perfect quality scores were achieved in the Medicare Merit-Based Incentive Payment System (MIPS) in two of the past three years and substantial improvements occurred in the practice’s Press-Ganey patient satisfaction scores. In 2020, USF Health completed an enhanced affiliation agreement with its primary teaching hospital, Tampa General, that includes integration of clinical services to form a robust, financially sound academic health center. The core of the integration is a 1,500-person management service organization, jointly owned by the university and hospital, termed USF Tampa General Physicians. This integration “de-risks” the university, provides much needed capital for expansion, and increases academic support.

Background information:

Internationally known for his research expertise in obstetrics and gynecology, Dr. Lockwood is credited with leading a research team that discovered fetal fibronectin (fFN), the first biochemical predictor of prematurity. His lab also uncovered the hemostatic and vascular mechanisms for contraceptive-associated abnormal uterine bleeding and link between down-regulation of progesterone receptor activity and various causes of preterm birth.  Dr. Lockwood maintains an active laboratory at USF Health dedicated to research in these areas. He and his team have been awarded five patents and have received multiple research grant awards from the NIH, the March of Dimes and other foundations.

He has chaired and/or served on multiple committees of the American College of Obstetricians and Gynecologists (ACOG), NIH, and the Food and Drug Administration. He served on the national board of the March of Dimes Foundation and is past president of the American Gynecological and Obstetrical Society, and the Society for Reproductive Investigation (SRI), the largest international reproductive science organization. Dr. Lockwood has been a tireless advocate for the training of physician-scientists.  He currently serves as a professional member of the Liaison Committee on Medical Education (LCME), which accredits U.S. allopathic medical schools. 

Dr. Lockwood is a prolific writer, having authored more than 310 peer-reviewed publications (Google H-index of 88; i10-index of 326; 29,072 citations), 290 editorials, textbook chapters, and reviews, authored or co-authored three books and co-edited seven major textbooks, three with multiple editions. He is the lead editor of the 9th Edition of Creasy & Resnik’s Maternal Fetal Medicine, the leading textbook in the field. He is obstetrics section editor for UpToDate and was the long-standing editor-in-chief of Contemporary OB/GYN, where his editorials won six national publication awards. 

 He has been elected to the National Academy of Medicine (formerly the Institute of Medicine) and the American Association for the Advancement of Science (AAAS). He is a recipient of the SRI President’s Distinguished Scientist Award, the Society for Maternal-Fetal Medicine’s Lifetime Achievement Award and the National Institute of Child Health and Human Development Frontiers in Reproduction Beacon Award for research mentorship. In addition, Dr. Lockwood is a recipient of the ACOG Public Service Award for his “enduring commitment to women’s health,” the Clotilde Dent Bowen Diversity and Inclusion Leadership Award from The Ohio State University College of Medicine, and the University of Maryland Dean’s Distinguished Gold Medal. 

Dr. Lockwood graduated magna cum laude from Brown University with special distinction in his major of developmental biology, received his medical degree from the University of Pennsylvania and a Master of Science degree in Healthcare Management.